Northwest Biotherapeutics Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Northwest Biotherapeutics Inc.

NWBO 0.232

-8.3%

Oct 29 3:58 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John McCarthy who wrote (737)	11/17/2018 1:34:11 PM
From: John McCarthy	of 759

investorshub.advfn.com But, many of us were right, 36 month data improved!!! Ha!!! Good luck to patients and longs. Latest results blended: 2017: 25.4 OS 36 months 2018 28.2 OS 36 months. Yes, I agree with Bigger. "Holy Shi_!!!" investorshub.advfn.com Ah, correct me if I'm wrong... but this is huge! I'm guessing they haven't unblinded anything, but this is the new 2018 interim data, correct? 25.4% of 331 = 84 28.2% of 331 = 93 So from this we can extrapolate that the last nine people who entered into the trial stayed alive the last year... this bodes incredibly well for the trial. If the drug didn't work you'd see those percentages stay the same or go down. We need the full unblinded results before making any true conclusions, but this is really positive news guys! investorshub.advfn.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next